9 research outputs found
The emerging role of nerves and glia in colorectal cancer
The role of the nervous system as a contributor in the tumor microenvironment has been recognized in different cancer types, including colorectal cancer (CRC). The gastrointestinal tract is a highly innervated organ system, which is not only innervated by the autonomic nervous system, but also contains an extensive nervous system of its own; the enteric nervous system (ENS). The ENS is important for gut function and homeostasis by regulating processes such as fluid absorption, blood flow, and gut motility. Dysfunction of the ENS has been linked with multiple gastrointestinal
In vivo transplantation of enteric neural crest cells into mouse gut; Engraftment, functional integration and long-term safety
Objectives: Enteric neuropathies are severe gastrointestinal disorders with unsatisfactory outcomes. We aimed to investigate the potential of enteric neural stem cell therapy approaches for such disorders by transplanting mouse enteric neural crest cells (ENCCs) into ganglionic and aganglionic mouse gut in vivo and analysing functional integration and long-term safety. Design: Neurospheres gene
Chronic intra-uterine Ureaplasma parvum infection induces injury of the enteric nervous system in ovine fetuses
Background: Chorioamnionitis, inflammation of the fetal membranes during pregnancy, is often
caused by intra-amniotic (IA) infection with single or multiple microbes. Chorioamnionitis can be
either acute or chronic, and is associated with adverse postnatal outcomes of the intestine, including
necrotizing enterocolitis (NEC). Neonates with NEC have structural and functional damage to the
intestinal mucosa and the enteric nervous system (ENS), with loss of enteric neurons and glial cells.
Yet, the impact of acute, chronic or repetitive antenatal inflammatory stimuli on the development of
the intestinal mucosa and ENS has not been studied. The aim of this study is therefore to investigate
the effect of acute, chronic and repetitive microbial exposure on the intestinal mucosa, submucosa
and ENS in premature lambs.
Materials and Methods: A sheep model of pregnancy was used in which the ileal mucosa, submucosa
and ENS were assessed following IA exposure to lipopolysaccharide (LPS) for 2 or 7 days (acute),
Ureaplasma parvum (UP) for 42 days (chronic) or repetitive microbial exposure (42 days UP with 2
or 7 days LPS).
Results: IA LPS exposure for 7 days or IA UP exposure for 42 days caused intestinal injury and
inflammation in the mucosal and submucosal layer of the gut. Repetitive microbial exposure did not
further aggravate injury of the terminal ileum. Chronic IA UP exposure caused significant structural
ENS alterations characterized by loss of PGP9.5 and S100β immunoreactivity whereas these changes
were not found after re-exposure of chronic UP-exposed fetuses to LPS for 2 or 7 days.
Conclusion: The in utero loss of PGP9.5 and S100β immunoreactivity following chronic UP
exposure corresponds with intestinal changes in neonates with NEC, and may therefore form a novel
mechanistic explanation for the association of chorioamnionitis and NEC
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2
The N-Myc Downstream-Regulated Gene 4 (NDRG4), a prominent biomarker for colorectal cancer (CRC), is specifically expressed by enteric neurons. Considering that nerves are important members of the tumor microenvironment, we here establish different Ndrg4 knockout (Ndrg4−/−) CRC models and an indirect co-culture of primary enteric nervous system (ENS) cells and intestinal organoids to identify whether the ENS, via NDRG4, affects intestinal tumorigenesis. Linking immunostainings and gastrointestinal motility (GI) assays, we show that the absence of Ndrg4 does not trigger any functional or morphological GI abnormalities. However, combining in vivo, in vitro, and quantitative proteomics data, we uncover that Ndrg4 knockdown is associated with enlarged intestinal adenoma development and that organoid growth is boosted by the Ndrg4−/− ENS cell secretome, which is enriched for Nidogen-1 (Nid1) and Fibulin-2 (Fbln2). Moreover, NID1 and FBLN2 are expressed in enteric neurons, enhance migration capacities of CRC cells, and are enriched in human CRC secretomes. Hence, we provide evidence that the ENS, via loss of Ndrg4, is involved in colorectal pathogenesis and that ENS-derived Nidogen-1 and Fibulin-2 enhance colorectal carcinogenesis
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2
The N-Myc Downstream-Regulated Gene 4 (NDRG4), a prominent biomarker for colorectal cancer (CRC), is specifically expressed by enteric neurons. Considering that nerves are important members of the tumor microenvironment, we here establish different Ndrg4 knockout (Ndrg4−/−) CRC models and an indirect co-culture of primary enteric nervous system (ENS) cells and intestinal organoids to identify whether the ENS, via NDRG4, affects intestinal tumorigenesis. Linking immunostainings and gastrointestinal motility (GI) assays, we show that the absence of Ndrg4 does not trigger any functional or morphological GI abnormalities. However, combining in vivo, in vitro, and quantitative proteomics data, we uncover that Ndrg4 knockdown is associated with enlarged intestinal adenoma development and that organoid growth is boosted by the Ndrg4−/− ENS cell secretome, which is enriched for Nidogen-1 (Nid1) and Fibulin-2 (Fbln2). Moreover, NID1 and FBLN2 are expressed in enteric neurons, enhance migration capacities of CRC cells, and are enriched in human CRC secretomes. Hence, we provide evidence that the ENS, via loss of Ndrg4, is involved in colorectal pathogenesis and that ENS-derived Nidogen-1 and Fibulin-2 enhance colorectal carcinogenesis
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2
The N‐Myc Downstream‐Regulated Gene 4 (NDRG4), a prominent biomarker for colorectal cancer (CRC), is specifically expressed by enteric neurons. Considering that nerves are important members of the tumor microenvironment, we here establish different Ndrg4 knockout (Ndrg4 (−/−)) CRC models and an indirect co‐culture of primary enteric nervous system (ENS) cells and intestinal organoids to identify whether the ENS, via NDRG4, affects intestinal tumorigenesis. Linking immunostainings and gastrointestinal motility (GI) assays, we show that the absence of Ndrg4 does not trigger any functional or morphological GI abnormalities. However, combining in vivo, in vitro, and quantitative proteomics data, we uncover that Ndrg4 knockdown is associated with enlarged intestinal adenoma development and that organoid growth is boosted by the Ndrg4 (−/−) ENS cell secretome, which is enriched for Nidogen‐1 (Nid1) and Fibulin‐2 (Fbln2). Moreover, NID1 and FBLN2 are expressed in enteric neurons, enhance migration capacities of CRC cells, and are enriched in human CRC secretomes. Hence, we provide evidence that the ENS, via loss of Ndrg4, is involved in colorectal pathogenesis and that ENS‐derived Nidogen‐1 and Fibulin‐2 enhance colorectal carcinogenesis